Evidence map›Paper›PMID 29636634›Full record

ReviewRisk management and healthcare policy2018

Triptych of the Hermit Saints: pneumococcal polysaccharide vaccines for the elderly.

Ger T Rijkers, Laura Ie Yousif, Simone Mc Spoorenberg, Frans J van Overveld

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Risk management and healthcare policy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Vaccines and Senior Travellers.Frontiers in aging · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Ger T RijkersDepartment of Science, University College Roosevelt, Middelburg, the Netherlands.
Laura Ie YousifDepartment of Science, University College Roosevelt, Middelburg, the Netherlands.
Simone Mc SpoorenbergDepartment of Internal Medicine, St Antonius Hospital, Nieuwegein, the Netherlands.
Frans J van OverveldDepartment of Science, University College Roosevelt, Middelburg, the Netherlands.
Roosevelt Institute for American Studies · NLSt. Antonius Ziekenhuis · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pneumococcal pneumonia is a serious disease with considerable morbidity and mortality in the elderly. Despite adequate antibiotic treatment, the long-term mortality of pneumococcal pneumonia remains high. Preventive measures in the form of vaccination, therefore, are warranted. Twenty-three-valent polysaccharide vaccines have a broad coverage but limited efficacy. Pneumococcal conjugate vaccines have been shown in children to be able to prevent invasive and mucosal pneumococcal diseases. It should be realized that the serotype composition of current pneumococcal conjugate vaccines is not tailored for the elderly, and that replacement disease can occur. Yet, the current 13-valent conjugate vaccine has been shown to protect against infections with vaccine serotypes. Long-term mortality of pneumococcal pneumonia should be included in policy making about the introduction of these vaccines for the elderly.

Indexed as

conjugate vaccinescost-effectivenesselderlypneumoniaStreptococcus pneumoniaevaccination

Identifiers

PMID29636634
PMCPMC5881283
OpenAlexW2792000784

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.